Stepwise into cancer

Cephalon Inc. has had a toehold in the cancer space since its 2000 acquisition of Anesta Corp. gave it Actiq oral transmucosal fentanyl, which is marketed for breakthrough cancer pain. The company also has two cancer compounds in the clinic. But with two recent

Read the full 446 word article

User Sign In